Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology. Di Grazia G, Sanchez-Bayona R, Casals-Pascual C, Pascual T, et al. NPJ Breast Cancer 2026 Jan 28. doi: 10.1038/s41523-026-00904.

Read + Share

Amedeo Smart

Independent Medical Education

Di Grazia G, Sanchez-Bayona R, Casals-Pascual C, Pascual T, et al. Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology. NPJ Breast Cancer 2026 Jan 28. doi: 10.1038/s41523-026-00904.
PMID: 41605941